17-74542880-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006678.5(CD300C):c.508G>A(p.Glu170Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,608,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006678.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD300C | NM_006678.5 | c.508G>A | p.Glu170Lys | missense_variant | 3/4 | ENST00000330793.2 | NP_006669.1 | |
CD300C | XM_017024033.3 | c.508G>A | p.Glu170Lys | missense_variant | 3/5 | XP_016879522.1 | ||
CD300C | XM_047435157.1 | c.611G>A | p.Arg204Gln | missense_variant | 3/4 | XP_047291113.1 | ||
LOC107985074 | XR_007065901.1 | n.237-297C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD300C | ENST00000330793.2 | c.508G>A | p.Glu170Lys | missense_variant | 3/4 | 1 | NM_006678.5 | ENSP00000329507 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000969 AC: 24AN: 247558Hom.: 0 AF XY: 0.0000671 AC XY: 9AN XY: 134206
GnomAD4 exome AF: 0.0000309 AC: 45AN: 1456148Hom.: 0 Cov.: 31 AF XY: 0.0000276 AC XY: 20AN XY: 724648
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2022 | The c.508G>A (p.E170K) alteration is located in exon 3 (coding exon 3) of the CD300C gene. This alteration results from a G to A substitution at nucleotide position 508, causing the glutamic acid (E) at amino acid position 170 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at